<bill session="117" type="hr" number="1284" updated="2023-03-08T19:58:48Z">
  <state datetime="2022-09-21">REPORTED</state>
  <status>
    <unknown datetime="2022-09-21"/>
  </status>
  <introduced datetime="2022-07-26"/>
  <titles>
    <title type="display">Of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House of Representatives relating to the negotiation of prices for prescription drugs under the Medicare prescription drug program.</title>
    <title type="official" as="introduced">Of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House of Representatives relating to the negotiation of prices for prescription drugs under the Medicare prescription drug program.</title>
  </titles>
  <sponsor bioguide_id="M001159"/>
  <cosponsors/>
  <actions>
    <action datetime="2022-07-26">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-07-26" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2022-07-27">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2022-09-21">
      <text>Subcommittee on Health Discharged.</text>
    </action>
    <action datetime="2022-09-21">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2022-09-21" state="REPORTED">
      <text>Ordered to be Reported Adversely by the Yeas and Nays: 31 - 22.</text>
    </action>
    <action datetime="2022-09-30">
      <text>Reported adversely by the Committee on Energy and Commerce. H. Rept. 117-534.</text>
    </action>
    <calendar datetime="2022-09-30" calendar="House" number="140">
      <text>Placed on the House Calendar, Calendar No. 140.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reporting, Markup, Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Discharged, Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Government information and archives"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-21T20:46:34Z" status="Reported to House">This resolution directs the Department of Health and Human Services (HHS) to furnish to the House of Representatives any external or internal communications of the White House regarding the implications of imposing certain penalties on drug manufacturers that do not comply with HHS price negotiations under the Medicare prescription drug benefit.</summary>
  <committee-reports>
    <report>H. Rept. 117-534</report>
  </committee-reports>
</bill>
